Sign inGet alerts
Special noticeFederal buyer

BioMerieux rapid microbial identification (ID) and antibiotic susceptibility testing

DEPT OF DEFENSE, Texas · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY
Verified 3 h agoLocal presence required
Responses dueMon, Oct 125:00 PM CT · Texas time3 days left
PostedWed, Oct 7No amendments since
Solicitation no.HT9408-27-Q-0003SAM.gov
Set-asideNoneOpen to all firms
Estimated value$135Kfrom notice

What the agency is buying

by RFPFinder from the notice; the solicitation governs

The Department of Defense Wilford Hall Ambulatory Surgical Center intends to procure a BioMérieux automated microbiology instrument with reagents and maintenance services. This is a sole-source contract awarded without competitive evaluation.

Scope

  • VITEK 2 60, AST, VC-VITEK, VC-BACT/ALERT VIRTUO systems with MAESTRIA data management
  • Reagents, maintenance services, and comprehensive support for rapid microbial ID and antibiotic susceptibility testing
Local presence requiredSubmission: emailDays to respond: 3

How to get the bid documents

  1. Open the notice on SAM.gov
  2. Read the notice; the source lists no attachments
  3. Submit by email before 5:00 PM CT on Oct 12

The source notice lists no attachments.

Open the original listing on SAM.gov

Details

Place of performance
JBSA Lackland, Texas
Buyer type
Federal
Notice type
Special Notice
Solicitation no.
HT9408-27-Q-0003
NAICS
NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing)
Size standard
1,250 employees SBA table, NAICS 325413
PSC
PSC 6550 (IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS)
Delivery location
Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base, Texas from notice
Period of performance
1 November 2026 through 31 October 2027 from notice
Estimated value
$135K from notice
Approved sources
BioMérieux, Inc. from notice
Local presence
Required
Amendments
None since Oct 7
Contact
Dulce Bares
Office
DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY
Email
dulce.i.bares.civ@health.mil

Not stated in the notice: contract type, quantity, FOB terms. Check the bid documents.

Contact details from the source notice. Contact the buyer only about this solicitation.

Key dates

Wed, Oct 7Posted
Not statedQuestions due
Mon, Oct 12 · 5:00 PM CTResponses due · 3 days left Under 14 days

Change log

verified Fri, Oct 9 · 11:30 PM CT

No amendments since posting on Wed, Oct 7; verified Fri, Oct 9 · 11:30 PM CT.

Report a problem

Notice as published

BioMerieux rapid microbial identification (ID) and antibiotic susceptibility testing

NOTICE OF INTENT TO SOLE SOURCE The Wilford Hall Ambulatory Surgical Center, Lackland MDTS/Laboratory Flight's intends to award a sole source contract with bioMrieux, Inc/, to procure a fully automated microbiology instrument that performs rapid microbial identification (ID) and antibiotic susceptibility testing via utilization systems VITEK 2 60, AST, VC-VITEK, and VC-BACT/ALERT VIRTUO systems with MAESTRIA data management. which includes all necessary reagents and comprehensive maintenance services for the Medical Treatment Facility (MTF) Wilford Hall. The Period of Performance is for one

  1. year beginning 1 November 2026 through 31 October 2027 in the amount of $135.373.31.

The contractor shall deliver the following crucial elements: Vitek2 and BacT/ALERT 3D with Myla Software, 3.1. System Capabilities - Fully automated immunoassay platform utilizing a solid-phase methodology for allergen-specific IgE detection. Capability to perform simultaneous testing of multiple allergens and allergen components from a single patient sample, VTK2 20CARDS GP, GN, YST, NH, ANC, AST-N809, GP67, YS09, VTK2 PIP/DIL.

Quantitative measurement of allergen-specific IgE antibodies. Minimal interference from othermunoglobulins (e.g., IgG).

Dimensions: (H/W/D): 215 x 183 x 105 cm, 3.2. Performance Requirements. High-throughput capability supporting large-scale laboratory operations.

Ability to produce 240 tests per hour with first result available in 100 minutes followed by one every 15 seconds. Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit, in writing. Responses must include clear and convincing evidence that competition would be beneficial to the Government and would not be cost or schedule prohibitive.

Respondents are responsible for appropriately marking any proprietary information. Responses will not be returned. This synopsis/notice of intent to sole source is issued in accordance with Federal Acquisition Regulation (FAR) Revolutionary FAR Overhaul (RFO) 5.101 and 12.102 and will be posted for 5 days.

Response Due Date: October 12, 2026 by 12:00 PM (CST) Submit to: Contracting Officer: Joe D. Wells at [email on the source notice].

What this office paid before

USAspending.gov, last 36 months

7 awards matched · tier 1: this contracting office (HT9408) + PSC 6550. Most recent:

  • Jul 8, 2026PHADIA US INCTWO (2) FULLY AUTOMATED PHADIA 1000 IMMUNOCAP SYSTEM ANALYZERS (LEASE AGREEMENT) FOR ALLERGY TESTING RESULTS (IMMUNOGLOBULIN E CLASS (IGE)),HT940826CE017 · DEFINITIVE CONTRACT · Defense Health Agency · ends Sep 29, 2026$2.5M
Pro

Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.

Sign in or upgrade

Awards updated Fri, Oct 9, 2026 · 11:51 PM CT.

This contracting office

32 other open notices from this office · buys mostly Other, Supplies & Equipment, Equipment Maintenance & Repair

Similar open RFPs

same PSC 6550

Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.

Alert meView on SAM.gov